BRCA1 and prostate carcinoma: To determine the clinical significance, we analyzed in MH BRCA retrospectively in 149 BRCA1/2 variant positive cases from a total of 346 patients with breast, ovarian, or prostate cancer, which were sequenced at the YCH to test for an indication of HBOC or HPC syndrome, respectively.